Skip to main content

and
  1. Article

    Open Access

    Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization

    Multimodal epigenetic characterization of cell-free DNA (cfDNA) could improve the performance of blood-based early cancer detection. However, integrative profiling of cfDNA methylome and fragmentome has been t...

    Fenglong Bie, Zhijie Wang, Yulong Li, Wei Guo, Yuanyuan Hong in Nature Communications (2023)

  2. Article

    Open Access

    Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study

    The most common form of treatment for non-metastatic lung cancer is surgery-based combination therapy, which may also include adjuvant radiotherapy or chemotherapy. Second primary malignancies (SPMs) are uncom...

    Bolun Zhou, Ruochuan Zang, Peng Song, Moyan Zhang in Journal of Translational Medicine (2023)

  3. Article

    Open Access

    Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians

    The characteristics of programmed cell death protein-1 (PD-L1) expression, tumor-infiltrating lymphocytes (TILs), and tumor microenvironment (TME) in lung adenocarcinoma (LUAD) patients are closely related to ...

    Fenglong Bie, He Tian, Nan Sun, Ruochuan Zang, Moyan Zhang in Clinical Epigenetics (2021)

  4. Article

    Open Access

    The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer

    Melanotransferrin (MFI2) is a newly identified tumor-associated protein, which consists of two forms of proteins, membrane-bound (mMFI2) and secretory (sMFI2). However, little is known about the expression pat...

    Yuanyuan Lei, Zhiliang Lu, Jianbing Huang, Ruochuan Zang, Yun Che in Cell Death & Disease (2020)

  5. Article

    Open Access

    ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells

    The abnormal secretion of CA125, a classic tumor marker, is usually related to a poor prognosis in various tumors. Thus, this study aimed to explore the potential mechanisms that promote CA125 secretion in lun...

    Yuanyuan lei, Ruochuan Zang, Zhiliang Lu, Guochao Zhang in Cell Death & Disease (2020)

  6. Article

    Open Access

    Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity

    Lung cancer is the leading cause of cancer-related death worldwide, and the timely and serial assessment of low-dose computed tomography (LDCT) in high-risk populations remains a challenge. Furthermore, testin...

    Ruochuan Zang, **nfeng Wang, Runsen **, Yuanyuan Lei in Journal of Translational Medicine (2019)

  7. No Access

    Article

    Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report

    Hub genes are good molecular candidates for targeted cancer therapy. As yet, however, there is little information on the clinical implications and functional characteristics of hub genes in the development of ...

    Jianbing Huang, Yuan Li, Zhiliang Lu, Yun Che, Shouguo Sun in Cellular Oncology (2019)

  8. Article

    Open Access

    Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance

    Preoperative chemotherapy is a promising strategy for the treatment of esophageal squamous cell carcinoma (ESCC). Acquired resistance to chemotherapy is a major obstacle in improving patient prognosis. Cancer-...

    Yun Che, **gnan Wang, Yuan Li, Zhiliang Lu, Jianbing Huang in Cell Death & Disease (2018)